InMed Pharmaceuticals, Inc.


Company Description:

InMed Pharmaceuticals Inc. (CSE:IN) (OTC:IMLFF) is a biopharmaceutical company specializing in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. 

The company is utilizing its proprietary Intelligent Cannabinoid Drug Design Platform "IDP" to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific diseases.

Latest News & Stories on InMed Pharmaceuticals, Inc. (CSE:IN) (OTC:IMLFF)